Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Shelley Wood

November 20, 2023

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

News Conference News PCR London Valves 2022

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

Shelley Wood

November 28, 2022

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Daily News

Television Viewing Time Linked to Higher Mortality From Pulmonary Embolism

L.A. McKeown

July 25, 2016

Presentation ECHO 2016

Pulmonary Hypertensionand the Role of Echo

Presenter: Madalina Petrescu

March 22, 2016

News Daily News

Upswing Seen in Pulmonary Artery Catheter Use in Acute Heart Failure

Todd Neale

December 06, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Daily News

肺动脉高压磨损可预测TAVR结果，可以帮助选择潜在适合者

Yael L. Maxwell

August 05, 2015

News Daily News

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

Yael L. Maxwell

August 05, 2015

News Daily News

El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos

Yael L. Maxwell

August 05, 2015

Presentation

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

Presenter: CJ. O'Sullivan

August 04, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

Advertisement

Debating the Role of T-TEER in the Sickest Patients

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Television Viewing Time Linked to Higher Mortality From Pulmonary Embolism

Pulmonary Hypertensionand the Role of Echo

Upswing Seen in Pulmonary Artery Catheter Use in Acute Heart Failure

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

肺动脉高压磨损可预测TAVR结果，可以帮助选择潜在适合者

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content